BMRN vs CDW · P/E 40, rev $2.85B vs P/E 22, rev $21.00B
Biomarin Pharmaceutical Inc (BMRN) versus CDW Corp (CDW) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
CDW Corp (CDW) is a information technology services company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Not investment advice. Open the BMRN and CDW stock pages for the full models.
Not investment advice.